Cargando…
Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort
PURPOSE: Alopecia areata (AA) is a common disorder of patchy hair loss which carries a substantial psychological burden for patients. The current understanding of AA prevalence, disease course and burden is limited, and further research is needed to improve patient care. This prospective cohort of A...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852234/ https://www.ncbi.nlm.nih.gov/pubmed/35173000 http://dx.doi.org/10.1136/bmjopen-2021-053137 |
_version_ | 1784653001951019008 |
---|---|
author | Andersen, Yuki M F Nymand, Lea DeLozier, Amy M Burge, Russel Edson-Heredia, Emily Egeberg, Alexander |
author_facet | Andersen, Yuki M F Nymand, Lea DeLozier, Amy M Burge, Russel Edson-Heredia, Emily Egeberg, Alexander |
author_sort | Andersen, Yuki M F |
collection | PubMed |
description | PURPOSE: Alopecia areata (AA) is a common disorder of patchy hair loss which carries a substantial psychological burden for patients. The current understanding of AA prevalence, disease course and burden is limited, and further research is needed to improve patient care. This prospective cohort of AA patients within the Danish Skin Cohort was established to provide data that can serve as a tool in future studies of for example, AA epidemiology and disease burden. PARTICIPANTS: A total of 1494 patients with dermatologist-verified AA were included in the cohort. Patients were invited and included through electronic or phone-based questionnaires. Information regarding demographics, biometrics, lifestyle factors, skin type, AA onset and development, health-related quality of life and self-reported severity assessment was collected. FINDINGS TO DATE: The mean (SD) age of AA onset was 32.7 (17.6) years. The mean body mass index and history of cigarette smoking was comparable with the general population. The majority (92.5%) of participants were Caucasian. In total, 72.4% of patients received their diagnosis by a physician within a year after onset of symptoms, and 66.9% reported to still have symptoms of AA within the past year. A total of 12% reported to have a first-degree family member with AA. In total, 31.4% of patients were missing all or nearly all hairs on their scalp, 32.2% had no or barely no eyelashes and 36.2% had no or barely no eyebrow hairs. Overall, most patients (55.7%) did not experience irritated eyes, but 30% reported slight eye irritation and 47.2% reported no damage to finger nails or toenails. FUTURE PLANS: Observational studies regarding comorbidities, psychosocial burden of AA and efficacy of pharmacological interventions will be carried out and additional data will be linked from nationwide registries of routinely collected data. Furthermore, follow-up survey data will be added for longitudinal analyses. |
format | Online Article Text |
id | pubmed-8852234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-88522342022-02-18 Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort Andersen, Yuki M F Nymand, Lea DeLozier, Amy M Burge, Russel Edson-Heredia, Emily Egeberg, Alexander BMJ Open Dermatology PURPOSE: Alopecia areata (AA) is a common disorder of patchy hair loss which carries a substantial psychological burden for patients. The current understanding of AA prevalence, disease course and burden is limited, and further research is needed to improve patient care. This prospective cohort of AA patients within the Danish Skin Cohort was established to provide data that can serve as a tool in future studies of for example, AA epidemiology and disease burden. PARTICIPANTS: A total of 1494 patients with dermatologist-verified AA were included in the cohort. Patients were invited and included through electronic or phone-based questionnaires. Information regarding demographics, biometrics, lifestyle factors, skin type, AA onset and development, health-related quality of life and self-reported severity assessment was collected. FINDINGS TO DATE: The mean (SD) age of AA onset was 32.7 (17.6) years. The mean body mass index and history of cigarette smoking was comparable with the general population. The majority (92.5%) of participants were Caucasian. In total, 72.4% of patients received their diagnosis by a physician within a year after onset of symptoms, and 66.9% reported to still have symptoms of AA within the past year. A total of 12% reported to have a first-degree family member with AA. In total, 31.4% of patients were missing all or nearly all hairs on their scalp, 32.2% had no or barely no eyelashes and 36.2% had no or barely no eyebrow hairs. Overall, most patients (55.7%) did not experience irritated eyes, but 30% reported slight eye irritation and 47.2% reported no damage to finger nails or toenails. FUTURE PLANS: Observational studies regarding comorbidities, psychosocial burden of AA and efficacy of pharmacological interventions will be carried out and additional data will be linked from nationwide registries of routinely collected data. Furthermore, follow-up survey data will be added for longitudinal analyses. BMJ Publishing Group 2022-02-16 /pmc/articles/PMC8852234/ /pubmed/35173000 http://dx.doi.org/10.1136/bmjopen-2021-053137 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Dermatology Andersen, Yuki M F Nymand, Lea DeLozier, Amy M Burge, Russel Edson-Heredia, Emily Egeberg, Alexander Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort |
title | Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort |
title_full | Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort |
title_fullStr | Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort |
title_full_unstemmed | Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort |
title_short | Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort |
title_sort | patient characteristics and disease burden of alopecia areata in the danish skin cohort |
topic | Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852234/ https://www.ncbi.nlm.nih.gov/pubmed/35173000 http://dx.doi.org/10.1136/bmjopen-2021-053137 |
work_keys_str_mv | AT andersenyukimf patientcharacteristicsanddiseaseburdenofalopeciaareatainthedanishskincohort AT nymandlea patientcharacteristicsanddiseaseburdenofalopeciaareatainthedanishskincohort AT delozieramym patientcharacteristicsanddiseaseburdenofalopeciaareatainthedanishskincohort AT burgerussel patientcharacteristicsanddiseaseburdenofalopeciaareatainthedanishskincohort AT edsonherediaemily patientcharacteristicsanddiseaseburdenofalopeciaareatainthedanishskincohort AT egebergalexander patientcharacteristicsanddiseaseburdenofalopeciaareatainthedanishskincohort |